Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study

The current crisis of the COVID-19 pandemic around the world has been devastating as many lives have been lost to the novel SARS CoV-2 virus. Thus, there is an urgent need for the right therapeutic drug to curb the disease. However, there is time constraint in drug development, hence the need for dr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Afr
Main Authors: Akinlalu, Alfred Olaoluwa, Chamundi, Annapoorna, Yakumbur, Donald Terseer, Afolayan, Funmilayo I. Deborah, Duru, Ijeoma Akunna, Arowosegbe, Michael Aderibigbe, Enejoh, Ojochenemi Aladi
Formato: Artigo
Idioma:Inglês
Publicado em: The Authors. Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8272888/
https://ncbi.nlm.nih.gov/pubmed/34308004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sciaf.2021.e00845
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados